Related Experiment Video

Updated: Jul 3, 2026

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells

Ilio Vitale1, Laura Senovilla, Lorenzo Galluzzi

  • 1INSERM, U848, Unit Apoptosis, Cancer and Immunity, Villejuif, France.

Cell Cycle (Georgetown, Tex.)
|July 22, 2008
PubMed

Insights

Inhibiting checkpoint kinase 1 (Chk1) triggers p38 mitogen-activated protein kinase (MAPK) activation, leading to p53 phosphorylation and apoptosis in tetraploid cancer cells. This pathway is crucial for eliminating polyploid cells therapeutically.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Tetraploid cancer cells undergo apoptosis via a p53-dependent pathway when Chk1 is inhibited.
  • Checkpoint kinase 1 (Chk1) plays a critical role in cell cycle regulation and DNA damage response.

Purpose of the Study:

  • To investigate the role of p38 MAPK in the Chk1-mediated apoptotic pathway in tetraploid cancer cells.
  • To elucidate the molecular mechanisms linking Chk1 inhibition to p53 activation and subsequent cell death.

Main Methods:

  • Utilized small interfering RNAs (siRNAs) to deplete Chk1 and p38alpha MAPK.
  • Employed pharmacological inhibition of Chk1 (UCN-01) and p38alpha MAPK (SB 203580).
  • Assessed p53 phosphorylation at serines 15 and 46 using Western blotting.

Main Results:

  • Chk1 inhibition induced activating phosphorylation of p38 MAPK.
  • Depletion of p38alpha MAPK abolished Chk1-knockdown-induced p53 phosphorylation at serines 15 and 46.
  • Inhibition of p38alpha MAPK reduced cell death caused by Chk1 knockdown or UCN-01.

Conclusions:

  • p38 MAPK acts as a pro-apoptotic kinase in the p53-dependent elimination of polyploid cells.
  • The p38 MAPK pathway is essential for mediating Chk1 inhibitor-induced apoptosis in tetraploid cancer cells.
  • Targeting the Chk1-p38 MAPK-p53 axis offers a potential therapeutic strategy for polyploidy-related cancers.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...